Aphelion
1 products tracked · names used in filings: Aphelion
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 06 Mar 2026🇺🇸 FDA approval
FDA approves Pylarify Truvu (piflufolastat f-18): new formulation or manufacturer
Aphelion; NDA220089; New formulation or manufacturer; solution · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Pylarify Truvu piflufolastat f-18 | Approved | 2026-03-06 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.